These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36958614)

  • 1. A triple fusion tissue-type plasminogen activator (TriF-ΔtPA) enhanced thrombolysis in carotid embolism-induced stroke model.
    Xu Y; Chen D; Liu P; Hu Y; Peng S; Chen S; Li Y; Lin W; Jiang L; Yuan C; Huang M
    Int J Pharm; 2023 Apr; 637():122878. PubMed ID: 36958614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific inhibition on PAI-1 reduces the dose of Alteplase for ischemic stroke treatment.
    Xu Y; Hu Y; Wu G; Niu L; Fang C; Li Y; Jiang L; Yuan C; Huang M
    Int J Biol Macromol; 2024 Feb; 257(Pt 2):128618. PubMed ID: 38070813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A low bleeding risk thrombolytic agent: citPA5.
    Chen S; Fang S; Zhou Y; Huang Z; Yu S; Chen D; Wang Z; Xu Y; Liu P; Li Y; Lin W; Jiang L; Yuan C; Huang M
    Cardiovasc Res; 2024 Sep; 120(10):1191-1201. PubMed ID: 38546342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of Peptide and Recombinant Tissue Plasminogen Activator Conjugated Poly(Lactic-Co-Glycolic Acid) (PLGA) Magnetic Nanoparticles for Dual Targeted Thrombolytic Therapy.
    Chen HA; Ma YH; Hsu TY; Chen JP
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32294917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A long-acting PAI-1 inhibitor reduces thrombus formation.
    Peng S; Xue G; Gong L; Fang C; Chen J; Yuan C; Chen Z; Yao L; Furie B; Huang M
    Thromb Haemost; 2017 Jun; 117(7):1338-1347. PubMed ID: 28405670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of thrombolytic therapies with mutant tPA (lanoteplase/SUN9216) and recombinant tPA (alteplase) for acute myocardial infarction.
    Ogata N; Ogawa H; Ogata Y; Numata Y; Morigami Y; Suefuji H; Soejima H; Sakamoto T; Yasue H
    Jpn Circ J; 1998 Nov; 62(11):801-6. PubMed ID: 9856594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. tPA Point Mutation at Autolysis Loop Enhances Resistance to PAI-1 Inhibition and Catalytic Activity.
    Peng S; Xue G; Chen S; Chen Z; Yuan C; Li J; Huang M
    Thromb Haemost; 2019 Jan; 119(1):77-86. PubMed ID: 30597502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VWF-targeted thrombolysis to overcome rh-tPA resistance in experimental murine ischemic stroke models.
    van Moorsel MVA; de Maat S; Vercruysse K; van Leeuwen EM; Jacqmarcq C; Bonnard T; Vivien D; van der Worp HB; Dijkhuizen RM; Maas C
    Blood; 2022 Dec; 140(26):2844-2848. PubMed ID: 35960811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal Structure of the Michaelis Complex between Tissue-type Plasminogen Activator and Plasminogen Activators Inhibitor-1.
    Gong L; Liu M; Zeng T; Shi X; Yuan C; Andreasen PA; Huang M
    J Biol Chem; 2015 Oct; 290(43):25795-804. PubMed ID: 26324706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of a novel chimeric tissue plasminogen activator with favorable Vampire bat plasminogen activator properties.
    Kazemali M; Majidzadeh-A K; Sardari S; Saadatirad AH; Khalaj V; Zarei N; Barkhordari F; Adeli A; Mahboudi F
    Enzyme Microb Technol; 2014 Dec; 67():82-6. PubMed ID: 25442953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. THR-18, a 18-mer peptide derived from PAI-1, is neuroprotective and improves thrombolysis by tPA in rat stroke models.
    Krakovsky M; Polianski V; Nimrod A; Higazi A; Leker RR; Lamensdorf I
    Neurol Res; 2011 Nov; 33(9):983-90. PubMed ID: 22081002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance.
    Zhu Y; Carmeliet P; Fay WP
    Circulation; 1999 Jun; 99(23):3050-5. PubMed ID: 10368124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced clot lysis by a single point mutation in a reteplase variant.
    Chen S; Chen D; Liu Y; Xu Y; Lin H; Cheng Y; Li J; Meng C; Liang M; Yuan C; Huang M
    Br J Haematol; 2022 Feb; 196(4):1076-1085. PubMed ID: 34783361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination treatment with N-acetyl-seryl-aspartyl-lysyl-proline and tissue plasminogen activator provides potent neuroprotection in rats after stroke.
    Zhang L; Chopp M; Teng H; Ding G; Jiang Q; Yang XP; Rhaleb NE; Zhang ZG
    Stroke; 2014 Apr; 45(4):1108-14. PubMed ID: 24549864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue Plasminogen Activator-Porous Magnetic Microrods for Targeted Thrombolytic Therapy after Ischemic Stroke.
    Hu J; Huang S; Zhu L; Huang W; Zhao Y; Jin K; ZhuGe Q
    ACS Appl Mater Interfaces; 2018 Oct; 10(39):32988-32997. PubMed ID: 30192506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a carotid artery thrombolysis stroke model in mice.
    Maclean JAA; Tomkins AJ; Sturgeon SA; Hofma BR; Alwis I; Samson AL; Schoenwaelder SM; Jackson SP
    Blood Adv; 2022 Sep; 6(18):5449-5462. PubMed ID: 35767737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New variant of human tissue plasminogen activator (TPA) with enhanced efficacy and lower incidence of bleeding compared with recombinant human TPA.
    Benedict CR; Refino CJ; Keyt BA; Pakala R; Paoni NF; Thomas GR; Bennett WF
    Circulation; 1995 Nov; 92(10):3032-40. PubMed ID: 7586274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activation and thrombolysis for ischemic stroke.
    Medcalf RL; Davis SM
    Int J Stroke; 2012 Jul; 7(5):419-25. PubMed ID: 22463085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and biologic properties of rt-PA del (K296-G302), a recombinant human tissue-type plasminogen activator deletion mutant resistant to plasminogen activator inhibitor-1.
    Li XK; Lijnen HR; Nelles L; Van Hoef B; Stassen JM; Collen D
    Blood; 1992 Jan; 79(2):417-29. PubMed ID: 1730087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newer thrombolytic agents.
    Verstraete M
    Ann Acad Med Singap; 1999 May; 28(3):424-33. PubMed ID: 10575530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.